¼¼°èÀÇ PEGÈ­ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)
Global PEGylation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1547303
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 181 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

PEGÈ­ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2024-2032³â ¿¬Æò±Õ 12.36%ÀÇ CAGR·Î 2023³â 20¾ï 3,000¸¸ ´Þ·¯¿¡¼­ 2032³â ¾à 58¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

PEGÈ­´Â Æú¸®¿¡Æ¿·» ±Û¸®ÄÝ(PEG, ¾àÇп¡¼­ ¸ÅÅ©·Î°ñÀ̶ó°íµµ ÇÔ) °íºÐÀÚ »ç½½À» ¾à¹°, Ä¡·á¿ë ´Ü¹éÁú, ¼ÒÆ÷¿Í °°Àº ºÐÀÚ ¶Ç´Â °Å½Ã ±¸Á¶¿¡ °øÀ¯ ¹× ºñ°øÀ¯ °áÇÕÀ¸·Î °áÇÕ ¶Ç´Â À¶ÇÕÇÏ´Â °úÁ¤ÀÔ´Ï´Ù. À¯µµÃ¼¿Í Ç¥Àû ºÐÀÚ¸¦ ÀÎÅ¥º£ÀÌÆÃÇÏ¿© ÀÌ·ç¾îÁý´Ï´Ù. ¾à¹°À̳ª Ä¡·á¿ë ´Ü¹éÁú¿¡ PEG¸¦ °øÀ¯ °áÇÕÇÏ¸é ¼÷ÁÖÀÇ ¸é¿ª ü°è¿¡¼­ ¾à¹°À» "¼û±æ"(¸é¿ª¿ø¼º ¹× Ç׿ø¼ºÀ» °¨¼Ò½ÃÅ´) ¼ö ÀÖÀ¸¸ç, À¯Ã¼ ¿ªÇÐÀû Å©±â(¿ë¾× ³» Å©±â)¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¼Ò¼ö¼º ÀǾàǰÀ̳ª ´Ü¹éÁúÀ» PEGÈ­ÇÏ¿© ¼ö¿ë¼ºÀ¸·Î ¸¸µé ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

Á¦¾à ¹× ¹ÙÀÌ¿ÀÁ¦¾à ±â¾÷ÀÇ ¿¬±¸°³¹ß ÅõÀÚ Áõ°¡, ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷ÀÇ È®´ë, »ýȰ½À°üº´ÀÇ À¯Çà, ´Ü¹éÁúÀÇ ¾ÈÁ¤¼º°ú ¼øÈ¯ ¹Ý°¨±â °³¼±¿¡ ´ëÇÑ °ü½É°ú ÀνÄÀÇ Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, PEGÈ­ ºÐÀÚ´Â ¹Ý°¨±â ¿¬Àå, µ¶¼º °¨¼Ò, ¸é¿ª¿ø¼º °¨¼Ò, ´Ü¹éÁú ºÐÇØ ¹æ¾î °­È­ µî ¸¹Àº ÀÌÁ¡À» Á¦°øÇϸç, ÀÌ ¸ðµç °ÍÀÌ ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀåÀÇ Áö¼ÓÀûÀÎ È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª PEGÈ­ °øÁ¤ÀÇ ºñ¿ë »ó½Â°ú ƯÁ¤ ÀǾàǰÀÇ Æ¯Çã ¸¸·á µîÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â PEGÈ­ ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Æ÷°ýÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖÀ¸¸ç, PEGÈ­ »ê¾÷ÀÇ ¼ºÀå°ú Ãß¼¼´Â ÀÌ Á¶»ç¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Á¢±Ù ¹æ½ÄÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

PEGÈ­ ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØÀÇ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡µéÀÌ ÇâÈÄ ±âȸ¸¦ ÅëÇØ °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °í°´À» ½Äº°ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ PEGÈ­ ½ÃÀåÀÇ ÇöÀç¿Í ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, ¸ðµç ÁÖ¿ä Áö¿ªÀÇ °³º° ÀÀ¿ë ºÐ¾ß¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¿äûÀÌ ÀÖÀ¸½Ã¸é ÀúÈñ¿¡°Ô ¿¬¶ô Áֽñ⠹ٶø´Ï´Ù. ´ç»çÀÇ Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå PEGÈ­ - »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå PEGÈ­ ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç° ¹× ¼­ºñ½ºº°

Á¦6Àå PEGÈ­ ¼¼°è ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå PEGÈ­ ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦8Àå PEGÈ­ ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå PEGÈ­ ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦10Àå PEGÈ­ ±â¾÷ °æÀï »óȲ

Á¦11Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for PEGylation Market is presumed to reach the market size of nearly USD 5.8 Billion by 2032 from USD 2.03 Billion in 2023 with a CAGR of 12.36% under the study period 2024-2032.

PEGylation (or pegylation) is the process of attaching or amalgamating polyethylene glycol (PEG, also known as macrogol in pharmacy) polymer chains to molecules and macrostructures, such as medication, therapeutic protein, or vesicle, in both covalent and non-covalent ways. PEGylation is commonly accomplished by incubating the target molecule with a reactive PEG derivative. The covalent attachment of PEG to a medication or therapeutic protein can ''''hide'''' the agent from the host's immune system (reduce immunogenicity and antigenicity) and enhance its hydrodynamic size (size in solution), which extends its circulation duration by reducing renal clearance. Hydrophobic medicines and proteins can also be PEGylated to make them water-soluble.

MARKET DYNAMICS

Increased R&D investments by pharmaceutical and biopharmaceutical companies, expansion in the biologics industry, rising prevalence of lifestyle illness, and increased attention and awareness on improving protein stability and circulation half-life are projected to drive market growth. Furthermore, as the number of people infected with chronic diseases rise, the PEGylation market will be fueled by the increased usage of PEGylated protein to treat various chronic diseases. PEGylated molecules provide many advantages, including a longer half-life, decreased toxicity, lower immunogenicity, and increased proteolytic protection, all contribute to the market's continued expansion. But on the other side, rising PEGylation process costs and the patent expiration of certain medications are expected to stifle market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of PEGylation. The growth and trends of PEGylation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the PEGylation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Services

By Type

By Application

By End-user

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the PEGylation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the PEGylation market include Thermo Fisher Scientific Inc., Abcam Plc, Enzon Pharmaceuticals Inc., Merck KGaA, Celares GmbH, Profacgen, Creative PEGworks, NOF America Corp., Aurigene Pharmaceutical Services Ltd., Laysan Bio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. PEGYLATION - INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL PEGYLATION MARKET ANALYSIS BY PRODUCT & SERVICES

6. GLOBAL PEGYLATION MARKET ANALYSIS BY TYPE

7. GLOBAL PEGYLATION MARKET ANALYSIS BY APPLICATION

8. GLOBAL PEGYLATION MARKET ANALYSIS BY END-USER

9. GLOBAL PEGYLATION MARKET ANALYSIS BY GEOGRAPHY

10. COMPETITIVE LANDSCAPE OF THE PEGYLATION COMPANIES

11. COMPANY PROFILES OF PEGYLATION INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â